Medical Intelligence Quiz
Challenge Yourself, Build Your Knowledge
Prevalence of preclinical Alzheimer’s disease
Question 1 of 5
Topics
Fast Facts Friday
Fast Facts Friday
| Quiz | |
|---|---|
| Fast Facts Friday: February 15, 2019 | Take Quiz |
| Fast Facts Friday: February 8, 2019 | Take Quiz |
| Fast Facts Friday: February 1, 2019 | Take Quiz |
Rare Diseases
Rare Diseases
| Quiz | |
|---|---|
| Laboratory testing in neurosarcoidosis | Take Quiz |
| Treatment of autoimmune encephalitides | Take Quiz |
| Symptoms of autoimmune encephalitides | Take Quiz |
| Comparing neuromyelitis optica spectrum disorder & MS | Take Quiz |
| Meningitis & fungal organisms | Take Quiz |
| Diesel exhaust exposure & ALS risk | Take Quiz |
| Symptom types & age of onset in Huntington’s disease | Take Quiz |
| Motor neuron disease symptoms | Take Quiz |
| Motor neuron disease testing | Take Quiz |
| Diagnosis & treatment of serotonin syndrome | Take Quiz |
| Etiology & features of serotonin syndrome | Take Quiz |
| ALS prevalence in the United States | Take Quiz |
| Cognitive status in patients with ALS | Take Quiz |
| Krabbe disease characteristics | Take Quiz |
| Chronic traumatic encephalopathy diagnosis | Take Quiz |
| Cerebral cavernous malformations | Take Quiz |
| Huntington’s disease: Neuroimmunology | Take Quiz |
| AAN Practice Parameter: Guillain-Barre syndrome immunotherapy | Take Quiz |
| Effects of myasthenia gravis | Take Quiz |
| Diagnosis of myasthenia gravis | Take Quiz |
| Pathology & etiology of Duchenne muscular dystrophy | Take Quiz |
| Presentation & clinical features of Duchenne muscular dystrophy | Take Quiz |
Headache & Migraine
Headache & Migraine
| Quiz | |
|---|---|
| Hemiplegic migraine symptoms | Take Quiz |
| Surgical intervention for migraine | Take Quiz |
| Diagnosing spontaneous intracranial hypotension | Take Quiz |
| Brain structure & posttraumatic headache | Take Quiz |
| Headache in subarachnoid hemorrhage | Take Quiz |
| Management of low-CSF-pressure headache | Take Quiz |
| Headache hygiene for pediatric migraine | Take Quiz |
| Headache from low CSF pressure | Take Quiz |
| Impact of migraine symptoms & attacks | Take Quiz |
| Acute confusional migraine | Take Quiz |
| Pediatric migraine & children’s drawings | Take Quiz |
| Effects of pain on treatments of acute migraine | Take Quiz |
| Allodynia in migraine | Take Quiz |
| Brain activations in migraine | Take Quiz |
| Brain structure & allodynia in migraine | Take Quiz |
| Migraine aura & premonitory symptoms | Take Quiz |
| Migraine risk & patient weight | Take Quiz |
| Migraine features and treatment | Take Quiz |
| Migraine comorbidity management | Take Quiz |
| Stroke among patients with migraine | Take Quiz |
| Migraine: Neural network activations | Take Quiz |
| Migraine & headache triggers | Take Quiz |
| Dietary factor of migraine | Take Quiz |
| Migraines and epilepsy | Take Quiz |
| Menstrual migraines | Take Quiz |
| Estrogen & pharmacologic management of migraine | Take Quiz |
| Adult migraine & childhood abuse | Take Quiz |
| Migraine among US veterans | Take Quiz |
| Acute migraine treatment pain relief success & failure | Take Quiz |
| Prevention of medication overuse migraine | Take Quiz |
| Coincidence of migraine & asthma | Take Quiz |
| Treatment of chronic migraine | Take Quiz |
| Migraine preventative management | Take Quiz |
| Chronic vs. episodic migraine | Take Quiz |
| Distinguishing chronic migraine from episodic migraine | Take Quiz |
| Exertional headache | Take Quiz |
| Migraine prevention therapy | Take Quiz |
| Incidence of migraine | Take Quiz |
| Headache from brain tumor | Take Quiz |
| Posttraumatic headache | Take Quiz |
| Risk of adult migraine due to childhood abuse | Take Quiz |
| Headache & blood pressure | Take Quiz |
| AAN guidelines: Evaluation and management of sports-related concussion | Take Quiz |
| AAN guidelines: Prevention of episodic migraine in adults | Take Quiz |
| Treating migraines | Take Quiz |
| Etiology and pathogenesis of migraine | Take Quiz |
| Chronic migraine & its effect on domesticity | Take Quiz |
| Migraines & headaches: Quality of care | Take Quiz |
Movement Disorders
Movement Disorders
| Quiz | |
|---|---|
| Anxiety and depression in cerebral palsy | Take Quiz |
| Treatment of essential tremor | Take Quiz |
| Diagnosis of essential tremor | Take Quiz |
| Clinical features of motor functional neurological disorder | Take Quiz |
| Neurological & psychiatric conditions in veterans with essential tremor | Take Quiz |
| Clinical aspects of functional neurological disorders | Take Quiz |
| Inflammatory bowel disease & Parkinson’s disease risk | Take Quiz |
| Differentiating neurogenic from nonneurogenic orthostatic hypotension | Take Quiz |
| Treating essential tremor with magnetic resonance-guided focused ultrasound | Take Quiz |
| Cerebellar motor dysfunction and ataxia | Take Quiz |
| Transcranial focused ultrasound & refractory essential tremor | Take Quiz |
| Deep brain stimulation in Parkinson’s disease | Take Quiz |
| Dystrophinopathy & dilated cardiomyopathy: Surgical considerations | Take Quiz |
| Diagnosing rare movement disorders | Take Quiz |
| Huntington’s disease preliminary diagnosis imaging | Take Quiz |
| Transcranial magnetic stimulation & essential tremor | Take Quiz |
| Outcomes of synucleinopathies with parkinsonism | Take Quiz |
| Dystonia location & secondary neuropsychiatric conditions | Take Quiz |
| Chorea characteristics in Huntington’s disease | Take Quiz |
| Huntington’s disease characteristics | Take Quiz |
| Impaired perception in progressive supranuclear palsy | Take Quiz |
| Essential tremor cerebellar signs | Take Quiz |
| Freezing of gait etiology | Take Quiz |
| Speech disorders following thalamic treatment of movement disorders | Take Quiz |
| Neuromyelitis optica: Restoring immune tolerance, Part 2 | Take Quiz |
| Effects of focused ultrasound thalamotomy | Take Quiz |
| Neuromyelitis optica: Restoring immune tolerance, Part 1 | Take Quiz |
| Perinatal neuroprotection | Take Quiz |
Neuro-oncology
Neuro-oncology
| Quiz | |
|---|---|
| Benign vs. malignant intracranial tumors | Take Quiz |
Alzheimer's & Cognition
Alzheimer's & Cognition
| Quiz | |
|---|---|
| Brain inflammation and cognitive decline | Take Quiz |
| Amyloid PET scans in cognitive impairment | Take Quiz |
| Stroke and dementia risk | Take Quiz |
| Diagnosing behavioral variant frontotemporal dementia | Take Quiz |
| Pregnancy and dementia risk | Take Quiz |
| Alzheimer’s dementia incidence | Take Quiz |
| Alzheimer’s dementia risk factors | Take Quiz |
| Mild cognitive impairment risk and antihypertensive therapies | Take Quiz |
| The role of microglia in Alzheimer’s disease | Take Quiz |
| Brain neuropathological features in Alzheimer’s disease and aging | Take Quiz |
| Impact of sex and gender in Alzheimer’s disease | Take Quiz |
| Alzheimer’s disease risk factors by patient sex & gender | Take Quiz |
| Ophthalmic conditions and Alzheimer's disease risk | Take Quiz |
| NIA-AA Research Framework: Defining Alzheimer’s disease | Take Quiz |
| Delusions & lesion network mapping | Take Quiz |
| Multiple sensory impairments & dementia risk | Take Quiz |
| Biomarkers for cerebrovascular & cognitive decline risk | Take Quiz |
| Comparing Alzheimer disease & Lewy body dementia features | Take Quiz |
| Alcoholism & regional brain shrinkage in elderly patients | Take Quiz |
| Risk of Alzheimer disease onset | Take Quiz |
| Excessive daytime sleepiness & dementia risk | Take Quiz |
| Features of α-synucleinopathies | Take Quiz |
| Criteria for Alzheimer disease diagnosis | Take Quiz |
| Alzheimer disease & circadian rhythm disturbance | Take Quiz |
| Subjective cognitive decline, tauopathy, & AD dementia | Take Quiz |
| Prevalence of preclinical Alzheimer’s disease | Take Quiz |
| Cognitive decline biomarkers after 80 years of age | Take Quiz |
| Traumatic brain injury, Alzheimer’s disease, & dementia | Take Quiz |
| Preventing AD with vitamin E | Take Quiz |
| Cognition impairment prevention via mentally stimulating activities | Take Quiz |
| Statins & Alzheimer’s disease risk | Take Quiz |
| Alzheimer’s disease and UPSIT | Take Quiz |
| Alzheimer’s disease & physical activity | Take Quiz |
| Measuring health effects of air pollution | Take Quiz |
| Late-life dementia risk from blood pressure | Take Quiz |
| Antipsychotic drug withdrawal effects in dementia patients | Take Quiz |
| Use of antipsychotics in elderly patients with dementia | Take Quiz |
| Cortical thinning & depression in elderly patients | Take Quiz |
| Alzheimer’s risk & Rab10 gene function | Take Quiz |
| Methods of dementia treatment | Take Quiz |
| Factors influencing Alzheimer disease biomarkers | Take Quiz |
| Dementia treatment with acetylcholinesterase inhibitors | Take Quiz |
| Alzheimer's disease risk from obstructive sleep apnea | Take Quiz |
| Amnestic mild cognitive impairment and driving | Take Quiz |
| Alzheimer’s disease risk from obstructive sleep apnea | Take Quiz |
| Plasma clusterin & risk of neurological diseases | Take Quiz |
| Lewy-body disease | Take Quiz |
| Testing for Alzheimer disease | Take Quiz |
| AIDS dementia complex | Take Quiz |
| AAN guidelines: Evaluation and management of driving risk in dementia | Take Quiz |
| Dietary approaches to Alzheimer prevention | Take Quiz |
| Practice guidelines: Alzheimer disease treatment | Take Quiz |
| Multimorbidity & cognitive impairment risk | Take Quiz |
| Amyloid imaging detection for Alzheimer disease | Take Quiz |
Epilepsy & Seizures
Epilepsy & Seizures
| Quiz | |
|---|---|
| Pharmacotherapies for HIV-associated cryptococcal meningitis | Take Quiz |
| Vascular risk factors and epilepsy risk | Take Quiz |
| Anxiety in epilepsy | Take Quiz |
| Epilepsy and risk of unnatural-cause mortality | Take Quiz |
| Differentiating pediatric epilepsy from GI disease | Take Quiz |
| FDA Approval: Oral cannabidiol for treatment of rare epilepsies | Take Quiz |
| Interactions between antiepileptic & nonepilepsy drugs in elderly patients | Take Quiz |
| AES Guidelines: Status epilepticus seizures | Take Quiz |
| AES Guidelines: Seizure treatment in adult patients with convulsive status epilepticus | Take Quiz |
| Premature mortality and epilepsy | Take Quiz |
| Brain effects of nonalcoholic fatty liver disease | Take Quiz |
| Alpers-Huttenlocher syndrome: Clinical features | Take Quiz |
| Epilepsy & suicide rate | Take Quiz |
| Examination prior to surgical management of epilepsy | Take Quiz |
| The Wada test and its alternatives | Take Quiz |
| Epilepsy treatment | Take Quiz |
| Childhood seizures in the United States | Take Quiz |
| Surgical treatment of epilepsy | Take Quiz |
| The treatment of GCSE/SE | Take Quiz |
| Epilepsy & patient welfare | Take Quiz |
| Genetics & epilepsy | Take Quiz |
| Managing epilepsy | Take Quiz |
| Classifying seizures & epilepsies | Take Quiz |
Stroke
Stroke
| Quiz | |
|---|---|
| Readmission to non-index hospital following acute stroke | Take Quiz |
| Covert vascular brain injury MRI markers in elderly patients | Take Quiz |
| Stroke and dementia risk | Take Quiz |
| Managing cerebrovascular issues in fibromuscular dysplasia | Take Quiz |
| Clinical features of carotid webs | Take Quiz |
| AHA/ASA Statement: Intracranial hemorrhage after systemic thrombolysis in acute ischemic stroke | Take Quiz |
| Diagnosis of cerebrovascular fibromuscular dysplasia | Take Quiz |
| Diagnosing primary CNS vasculitis | Take Quiz |
| Lacunar stroke & cerebral small vessel disease | Take Quiz |
| Neurologic disease risk by age and sex | Take Quiz |
| Incidental findings from stroke radiographic imaging | Take Quiz |
| Calcium & magnesium levels in intracranial bleeding | Take Quiz |
| Stroke mimics & chameleons in the ED | Take Quiz |
| Intracerebral hemorrhage recurrence risk & ethnicities | Take Quiz |
| Evaluating stroke in the emergency department | Take Quiz |
| The state of stroke prevention | Take Quiz |
| Stroke in patients with nonvalvular atrial fibrillation | Take Quiz |
| Emergency management of stroke | Take Quiz |
| Patent foramen ovale and perioperative ischemic stroke | Take Quiz |
| Stroke risk & smoking in young adult males | Take Quiz |
| AHA/ASA Guidelines: Stroke management & prevention | Take Quiz |
| Spastic arm paralysis and nerve transfer treatment | Take Quiz |
| AHA/ASA Guidelines for acute ischemic stroke: Mechanical thrombectomy | Take Quiz |
| AHA/ASA Guidelines for acute ischemic stroke: Intravenous tissue plasminogen activator | Take Quiz |
| Thrombectomy after stroke | Take Quiz |
| Clinical evaluation of stroke | Take Quiz |
| Stroke treatment & patient sex | Take Quiz |
| Stroke occurrence by patient sex | Take Quiz |
| Stroke motor recovery and tDCS | Take Quiz |
| Stroke & cirrhosis associations | Take Quiz |
| Post-stroke cognitive impairment & dementia | Take Quiz |
| Effects of diabetes in stroke | Take Quiz |
| Acute ischemic stroke management methods | Take Quiz |
| Poststroke motor recovery & spasticity | Take Quiz |
| Tissue plasminogen activator treatment of stroke | Take Quiz |
| The choroid plexus, CSF, & stroke | Take Quiz |
| Stroke features: Ischemic versus hemorrhagic | Take Quiz |
| Patient age & stroke risk | Take Quiz |
| Etiologic stroke subtypes | Take Quiz |
| Stroke and risk of familial late-onset Alzheimer disease | Take Quiz |
| Strokelike episodes in MELAS mitochondrial syndrome | Take Quiz |
| Poststroke aphasia recovery | Take Quiz |
| AHA/ASA Scientific Statement: Investigating vascular risks in silent cerebrovascular disease | Take Quiz |
| Neuroimaging of silent cerebrovascular disease | Take Quiz |
| Silent cerebrovascular disease variants & stroke risk | Take Quiz |
| AHA/ASA Guidelines: Post-stroke therapy approaches | Take Quiz |
| Stroke & silent cerebrovascular disease | Take Quiz |
| Carotid artery interventions & cognitive function | Take Quiz |
| Treatment of stroke survivors with transcranial direct current stimulation | Take Quiz |
| Aspirin & recurrent ischemic stroke risk | Take Quiz |
| Intracerebral hemorrhage management via blood pressure control | Take Quiz |
| AHA/ASA Guidelines: Adult stroke rehabilitation & recovery | Take Quiz |
Parkinson's Disease
Parkinson's Disease
| Quiz | |
|---|---|
| Predictors of life expectancy in Parkinson disease, Part 2 | Take Quiz |
| Predictors of life expectancy in Parkinson disease, Part 1 | Take Quiz |
| Appendectomy and Parkinson’s disease | Take Quiz |
| Type 2 diabetes and Parkinson’s disease risk | Take Quiz |
| Treating motor symptoms of Parkinson's disease | Take Quiz |
| REM sleep behavior disorder in Parkinson’s disease | Take Quiz |
| CNS Guidelines: Deep brain stimulation target selection in Parkinson’s disease | Take Quiz |
| Neurogenic orthostatic hypotension in Parkinson’s disease | Take Quiz |
| Autonomic dysfunction in Parkinson’s disease | Take Quiz |
| Parkinson’s disease & type 2 diabetes risk | Take Quiz |
| TBI & Parkinson’s disease risk among US veterans | Take Quiz |
| Parkinson’s disease pathology | Take Quiz |
| Exercise & Parkinson disease management | Take Quiz |
| Features of α-synucleinopathies | Take Quiz |
| Caffeine & Parkinson’s disease | Take Quiz |
| Deep brain stimulation targets for Parkinson disease | Take Quiz |
| Eye movement abnormalities in Parkinson’s disease | Take Quiz |
| Early-onset Parkinson’s disease psychosis | Take Quiz |
| Parkinson’s disease & light therapy | Take Quiz |
| Parkinson’s disease & GCH1 mutation | Take Quiz |
| Cardiovascular risk & statin use in patients with Parkinson’s disease | Take Quiz |
| Parkinson’s disease: Effect of diet & exercise | Take Quiz |
| Parkinson’s disease and parkinsonism incidence | Take Quiz |
| Parkinson disease from genetic mutation | Take Quiz |
| Lewy-body disease | Take Quiz |
| BMI and Parkinson disease | Take Quiz |
| TBI as predictor of Parkinson disease | Take Quiz |
| Supportive criteria in MDS diagnosis of Parkinson’s disease | Take Quiz |
| MDS diagnostic red flags for clinically probable Parkinson disease | Take Quiz |
| MDS criteria for Parkinson disease diagnosis | Take Quiz |
| Treating Parkinson disease | Take Quiz |
| Pathogenesis and pathology of Parkinson disease | Take Quiz |
| Muscle strength & Parkinson disease | Take Quiz |
| Diagnosis & prognosis of new onset Parkinson disease | Take Quiz |
| Alternative strategies for the treatment of Parkinson disease | Take Quiz |
| Motor fluctuations & dyskinesia in Parkinson disease | Take Quiz |
| Parkinson disease: Exercise & quality of life | Take Quiz |
| Diagnosing Parkinson disease | Take Quiz |
| Recognizing the clinical features of Parkinson disease | Take Quiz |
| Motor & nonmotor features in Parkinson disease | Take Quiz |
| Parkinsonism: Prominence & causes | Take Quiz |
Pain
Pain
| Quiz | |
|---|---|
| Low back pain chronicity and treatment | Take Quiz |
| Prevalence of opioid use in ED treatment of ankle sprain | Take Quiz |
| Treatment of opioid use disorder | Take Quiz |
| PAINWeek Coverage: Central sensitization pain syndromes & ketamine | Take Quiz |
| Cannabis and noncancer pain relief | Take Quiz |
| Clinical features of “chasing the dragon” heroin abuse | Take Quiz |
| Opioid vs. nonopioid treatments for chronic pain | Take Quiz |
| Cannabis, cannabinoid, and marijuana use clinical effects | Take Quiz |
| ACP Guidelines: Treatment of low back pain, Part 2 | Take Quiz |
| ACP Guidelines: Treatment of low back pain, Part 1 | Take Quiz |
| APS/ASA Guidelines: Management of postoperative pain | Take Quiz |
| Postherpetic neuralgia | Take Quiz |
| Etiology of back pain: Part 2 | Take Quiz |
| Etiology of back pain: Part 1 | Take Quiz |
| Understanding severe brain injury | Take Quiz |
| Treatment options for pain | Take Quiz |
| Signs and symptoms of cervical disc herniation | Take Quiz |
| Pain assessment and management | Take Quiz |
| Pain assessment | Take Quiz |
| The physiologic aspects of pain | Take Quiz |
| AAN guidelines: Prevention of episodic migraine with NSAIDs and other therapies | Take Quiz |
| Cannabinoids across indications | Take Quiz |
| MS & patient perception of pain | Take Quiz |
| Chronic migraine & its effect on domesticity | Take Quiz |
Clinical Guidelines
Clinical Guidelines
| Quiz | |
|---|---|
| AAN Guidelines: Disorders of consciousness | Take Quiz |
| CDC Guideline: Mild traumatic brain injury among children | Take Quiz |
| AASM Position Statement: Medical cannabis & OSA treatment | Take Quiz |
| AAN Guidelines: Adjusting disease-modifying therapies in patients with MS | Take Quiz |
| AAN Guidelines: Starting disease-modifying therapies in patients with MS | Take Quiz |
| 2017 revisions of the McDonald criteria: Role of CSF in MS diagnosis | Take Quiz |
| 2017 revisions of the McDonald criteria: Role of MRI in MS diagnosis | Take Quiz |
| 2017 revisions of McDonald criteria: Diagnostic criteria for MS | Take Quiz |
| Cerebellar motor dysfunction and ataxia | Take Quiz |
| AES Guidelines: Status epilepticus seizures | Take Quiz |
| APTA Neurology Guidelines: Rehabilitation of vestibular hypofunction | Take Quiz |
| AES Guidelines: Seizure treatment in adult patients with convulsive status epilepticus | Take Quiz |
| ACP Guidelines: Treatment of low back pain, Part 2 | Take Quiz |
| ACP Guidelines: Treatment of low back pain, Part 1 | Take Quiz |
| Restless legs syndrome clinical features | Take Quiz |
| AAN Practice Guidelines: Restless legs syndrome management | Take Quiz |
| AAN Practice Parameter: Emergency CT | Take Quiz |
| AAN Guidelines: Serum prolactin assay for epileptic seizures | Take Quiz |
| AHS Guidelines: Cluster headache acute & prophylactic therapies | Take Quiz |
| AAN/AANEM/AAPM&R Practice Parameter: Evaluating DSP | Take Quiz |
| AAN Guidelines: Periprocedural antithrombotic medication use | Take Quiz |
| AAN Guideline: Parenchymal neurocysticercosis management | Take Quiz |
| AHA/ASA Guidelines: Adult stroke rehabilitation & recovery | Take Quiz |
| AAN Guidelines: Effectiveness of MS rehabilitation therapies | Take Quiz |
| AAN guidelines: Evaluation and management of sports-related concussion | Take Quiz |
| AAN guidelines: Prevention of episodic migraine with NSAIDs and other therapies | Take Quiz |
| AAN guidelines: Prevention of episodic migraine in adults | Take Quiz |
| AAN guidelines: Evaluation, diagnosis and management of FSHD | Take Quiz |
| AAN guidelines: Evaluation and management of driving risk in dementia | Take Quiz |
| AAN Guidelines: Treatment of chorea in Huntington disease | Take Quiz |
Neurology
Neurology
| Quiz | |
|---|---|
| AAN Guidelines: Disorders of consciousness | Take Quiz |
| CDC Guideline: Mild traumatic brain injury among children | Take Quiz |
| AASM Position Statement: Medical cannabis & OSA treatment | Take Quiz |
| AAN Guidelines: Adjusting disease-modifying therapies in patients with MS | Take Quiz |
| AAN Guidelines: Starting disease-modifying therapies in patients with MS | Take Quiz |
| 2017 revisions of the McDonald criteria: Role of MRI in MS diagnosis | Take Quiz |
| 2017 revisions of McDonald criteria: Diagnostic criteria for MS | Take Quiz |
| AES Guidelines: Status epilepticus seizures | Take Quiz |
| ACP Guidelines: Treatment of low back pain, Part 2 | Take Quiz |
| ACP Guidelines: Treatment of low back pain, Part 1 | Take Quiz |
| AAN Practice Guidelines: Restless legs syndrome management | Take Quiz |
| AAN Guidelines: Serum prolactin assay for epileptic seizures | Take Quiz |
| AHS Guidelines: Cluster headache acute & prophylactic therapies | Take Quiz |
| AAN Guidelines: Periprocedural antithrombotic medication use | Take Quiz |
| AAN Guideline: Parenchymal neurocysticercosis management | Take Quiz |
| AHA/ASA Guidelines: Adult stroke rehabilitation & recovery | Take Quiz |
| AAN Guidelines: Effectiveness of MS rehabilitation therapies | Take Quiz |
| AAN guidelines: Evaluation and management of sports-related concussion | Take Quiz |
| AAN guidelines: Prevention of episodic migraine with NSAIDs and other therapies | Take Quiz |
| AAN guidelines: Evaluation, diagnosis and management of FSHD | Take Quiz |
Multiple Sclerosis
Multiple Sclerosis
| Quiz | |
|---|---|
| Multiple sclerosis and pregnancy | Take Quiz |
| Comparing neuromyelitis optica spectrum disorder & MS | Take Quiz |
| Demyelination in myelocortical multiple sclerosis | Take Quiz |
| Brain atrophy in multiple sclerosis | Take Quiz |
| Clinical assessment of walking motion in patients with MS | Take Quiz |
| Fall risk in MS patients using a wheeled mobility device | Take Quiz |
| Vitamin levels in patients with MS | Take Quiz |
| Brain matter volume & disability progression in MS | Take Quiz |
| AAN Guidelines: Adjusting disease-modifying therapies in patients with MS | Take Quiz |
| AAN Guidelines: Starting disease-modifying therapies in patients with MS | Take Quiz |
| Disease-modifying therapies for relapsing-remitting MS | Take Quiz |
| Complementary & alternative treatments for MS | Take Quiz |
| 2017 revisions of the McDonald criteria: Role of CSF in MS diagnosis | Take Quiz |
| 2017 revisions of the McDonald criteria: Role of MRI in MS diagnosis | Take Quiz |
| 2017 revisions of McDonald criteria: Diagnostic criteria for MS | Take Quiz |
| ECTRIMS/EAN Guideline: Pharmacologic treatment of MS | Take Quiz |
| Disease-modifying therapy in MS treatment | Take Quiz |
| Falls & mobility device use among patients with MS | Take Quiz |
| Diet & gut microbiota in multiple sclerosis | Take Quiz |
| MS symptoms and the cerebellum | Take Quiz |
| Vitamin D as a factor in MS | Take Quiz |
| Cerebellar dysfunction in MS | Take Quiz |
| Prognosis of MS from MRI findings | Take Quiz |
| MRI imaging in MS diagnosis | Take Quiz |
| Psoriasis occurrence in MS | Take Quiz |
| Factor of immune response cells in MS | Take Quiz |
| MS treatment with monoclonal antibodies | Take Quiz |
| MS incidence & sex hormones | Take Quiz |
| MS differences by patient sex | Take Quiz |
| Role of hormones in MS disease course | Take Quiz |
| Detection & evaluation of MS relapse | Take Quiz |
| Ocrelizumab efficacy in MS | Take Quiz |
| Progressive & relapsing-remitting MS | Take Quiz |
| Primary & secondary progressive MS | Take Quiz |
| Multiple sclerosis & leptomeningeal enhancement | Take Quiz |
| MRI & MS biomarkers | Take Quiz |
| Signs of asymptomatic MS | Take Quiz |
| Effect of personality on memory in MS | Take Quiz |
| MS prevalence external factors | Take Quiz |
| Impact of smoking in patients with MS | Take Quiz |
| MS severity and cognitive impairment | Take Quiz |
| Effect of MS on elderly patients by gender | Take Quiz |
| MS & emotional conditions | Take Quiz |
| MS patient exercise & sleep improvement | Take Quiz |
| Spasticity in MS | Take Quiz |
| Bowel dysfunction in MS | Take Quiz |
| MS exacerbations & pseudoexacerbations | Take Quiz |
| Role of diet in MS management | Take Quiz |
| Smoking & MS | Take Quiz |
| Pain in MS | Take Quiz |
| Genetic bases of MS risk | Take Quiz |
| MS diagnosis & McDonald criteria | Take Quiz |
| AAN Guidelines: MS & psychiatric disorders | Take Quiz |
| Benign MS factors | Take Quiz |
| Tremor in MS | Take Quiz |
| Prevalence of MS variants | Take Quiz |
| Effect of MS on mortality | Take Quiz |
| MS and Hodgkin Lymphoma commonalities | Take Quiz |
| Physical activity engagement among MS patients | Take Quiz |
| Methods of surgical treatment for MS bladder conditions | Take Quiz |
| MS & brain iron | Take Quiz |
| Body fluid markers in MS | Take Quiz |
| Health of MS patient caregivers | Take Quiz |
| Effect of patient sex on MS comorbidity incidence | Take Quiz |
| AAN Guidelines: Effectiveness of MS rehabilitation therapies | Take Quiz |
| Comorbidities & mortality in patients with MS | Take Quiz |
| Treatment of MS | Take Quiz |
| Diagnostic criteria for MS | Take Quiz |
| Clinical manifestations of MS | Take Quiz |
| Etiology & epidemiology of MS | Take Quiz |
| Immunopathogenesis, diagnosis, and treatment of MS | Take Quiz |
| Effect of DMT on CIS & MS | Take Quiz |
| Coffee consumption & MS risk | Take Quiz |
| MS & optic neuritis | Take Quiz |
| MS & discontinuation of DMT | Take Quiz |
| Adherence to MS treatment: Oral & injectable | Take Quiz |
| Identifying neuromyelitis optica spectrum disorder | Take Quiz |
| MS & B cells | Take Quiz |
| MS & patient perception of pain | Take Quiz |
Pediatrics
Pediatrics
| Quiz | |
|---|---|
| ADHD among US children | Take Quiz |
| CDC Guideline: Mild traumatic brain injury among children | Take Quiz |
| Differentiating pediatric epilepsy from GI disease | Take Quiz |
| AAP Guideline: Nutrition for infant neurodevelopment | Take Quiz |
| Headache hygiene for pediatric migraine | Take Quiz |
| Postsurgical medical opioid use risk among adolescents | Take Quiz |
| Neurologic effects of junk food on adolescent patients | Take Quiz |
| Parental mosaicism in pediatric epileptic encephalopathy | Take Quiz |
Neuromuscular Disorders
Neuromuscular Disorders
| Quiz | |
|---|---|
| Neurologic disease risk by age and sex | Take Quiz |
| Polyneuropathy among patients with obesity | Take Quiz |
| ALS features & causes | Take Quiz |
| ALS development risk | Take Quiz |
| Thymectomy & myasthenia gravis management | Take Quiz |
| Neuromuscular disorder features | Take Quiz |
| ALS development risk factors | Take Quiz |
| AAN Practice Parameter: Guillain-Barre syndrome immunotherapy | Take Quiz |
Traumatic Brain Injury
Traumatic Brain Injury
| Quiz | |
|---|---|
| Traumatic brain injury and suicide risk | Take Quiz |
| TBI & Parkinson’s disease risk among US veterans | Take Quiz |
| Tackle football first-exposure age & neurological conditions | Take Quiz |
| Traumatic brain injury severity & dementia risk | Take Quiz |
| Football and chronic traumatic encephalopathy | Take Quiz |
| Traumatic brain injury outcomes in military service members | Take Quiz |
| Traumatic brain injury, Alzheimer’s disease, & dementia | Take Quiz |
| TBI recovery & sleep-wake cycle health | Take Quiz |
| Post-TBI depression prevention | Take Quiz |
| Blood biomarkers of brain injury | Take Quiz |
| Evaluating severe brain injury | Take Quiz |
| Defining and evaluating concussion and severe brain injury | Take Quiz |
| Unemployment rates in veterans with TBI | Take Quiz |
FDA Actions
FDA Actions
| Quiz | |
|---|---|
| FDA Approval: IncobotulinumtoxinA for chronic sialorrhea | Take Quiz |
Sleep Medicine
Sleep Medicine
| Quiz | |
|---|---|
| OSA & metabolic syndrome | Take Quiz |
| REM sleep behavior disorder & synucleinopathies | Take Quiz |
| Recent trends in sleep among US patients | Take Quiz |
| AASM Position Statement: Medical cannabis & OSA treatment | Take Quiz |
| Narcolepsy features & diagnosis | Take Quiz |
| Excessive daytime sleepiness & dementia risk | Take Quiz |
| Daytime sleepiness in obstructive sleep apnea | Take Quiz |
| Insomnia among US soldiers | Take Quiz |
| Older adult patients & sleep disorder incidence | Take Quiz |
| Understanding sleep disorders | Take Quiz |
| The physiology of sleep | Take Quiz |
| Sleep deprivation and sleep-related disorders | Take Quiz |
| Neurologic signs of insomnia | Take Quiz |
| Insomnia disorder | Take Quiz |
| Insomnia assessment & treatment optionsInsomnia assessment & treatment options | Take Quiz |
| Insomnia: Prevalence & patient population | Take Quiz |
| IOM calls for new chronic fatigue syndrome criteria: Part 3 | Take Quiz |
| Insomnia assessment & treatment options | Take Quiz |
| IOM calls for new chronic fatigue syndrome criteria: Part 2 | Take Quiz |
Neurogenic Orthostatic Hypotension
Neurogenic Orthostatic Hypotension
| Quiz | |
|---|---|
| Neurogenic & non-neurogenic orthostatic hypotension | Take Quiz |
| Supine hypertension in neurogenic orthostatic hypotension | Take Quiz |
| Evaluating for neurogenic orthostatic hypotension | Take Quiz |
GBS/CIDP
GBS/CIDP
| Quiz | |
|---|---|
| Chronic inflammatory demyelinating polyneuropathy management | Take Quiz |
| Chronic inflammatory demyelinating polyneuropathy features & diagnosis | Take Quiz |
| Guillain-Barré syndrome management & outcomes | Take Quiz |
| Guillain-Barré syndrome symptoms & diagnosis | Take Quiz |
AAN Conference Coverage: MS
AAN Conference Coverage: MS
| Quiz | |
|---|---|
| Personality & cognitive status in MS | Take Quiz |
| Brain atrophy & cognitive outcomes in MS | Take Quiz |
| Findings of the vsMS global survey | Take Quiz |
| Fingolimod RRMS treatment effectiveness | Take Quiz |
| Secondary progressive MS conversion | Take Quiz |
| Treating progressive MS with EBV-specific T cells | Take Quiz |
Lennox-Gastaut Syndrome
Lennox-Gastaut Syndrome
| Quiz | |
|---|---|
| Lennox-Gastaut syndrome classification | Take Quiz |
| Lennox-Gastaut syndrome development | Take Quiz |
| Characteristics of Lennox-Gastaut syndrome | Take Quiz |
| Lennox-Gastaut syndrome & West syndrome compared | Take Quiz |
| Lennox-Gastaut syndrome characteristics & development | Take Quiz |
| Lennox-Gastaut syndrome manifestation | Take Quiz |
| Lennox-Gastaut syndrome surgical management | Take Quiz |
| Dietary management of Lennox-Gastaut syndrome | Take Quiz |
| Lennox-Gastaut syndrome occurrence & causes | Take Quiz |
| Lennox-Gastaut syndrome outcomes | Take Quiz |
| Diagnosis of Lennox-Gastaut syndrome: Part 2 | Take Quiz |
| Diagnosis of Lennox-Gastaut syndrome: Part 1 | Take Quiz |
| Quiz | |
|---|---|
| Parkinsonian tremor | Take Quiz |
| Stroke risk: Combination vs monotherapy therapy | Take Quiz |